載入...
In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model
We have recently reported that, after in vivo hematopoietic stem cell/progenitor (HSPC) transduction with HDAd5/35++ vectors, SB100x transposase-mediated γ-globin gene addition achieved 10%–15% γ-globin of adult mouse globin, resulting in significant but incomplete phenotypic correction in a thalass...
Na minha lista:
| 發表在: | Mol Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Gene & Cell Therapy
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854285/ https://ncbi.nlm.nih.gov/pubmed/32949495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.09.001 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|